Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol to take $1.8 billion charge on hepatitis C drug failure
Bristol to take $1.8 billion charge on hepatitis C drug failure
Bristol to take $1.8 billion charge on hepatitis C drug failure
Submitted by
admin
on August 24, 2012 - 10:33am
Source:
Reuters
News Tags:
Bristol-Myers Squibb
hepatitis C
BMS-986094
Headline:
Bristol to take $1.8 billion charge on hepatitis C drug failure
Do Not Allow Advertisers to Use My Personal information
